STRATA Skin Sciences surges on U.S. launch of acne treatment
** Shares of STRATA Skin Sciences SSKN.O climb as much as
~31% to $1.44 before the bell
** Late on Monday, medtech co announced commercial launch of
its TheraClearX acne therapy system urn:newsml:reuters.com:*:nGNX30BZfz
** TheraClearX is a non-invasive and pain-free treatment
system for mild to moderate acne
** SSKN adds that it is currently exploring strategic
partners internationally
** As of last close, stock down about 25% YTD
(Reporting by Bhanvi Satija in Bengaluru)
((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))
Recent news on STRATA Skin Sciences
See all newsBrief: Strata Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan As Chief Executive Officer
Brief: Laseroptek America Filed Counterclaims & Third-Party Claims Against Strata Skin Sciences & Its CEO, In Lawsuit Brought By Strata
Medical tech firm STRATA's Q3 revenue misses estimates as demand in international markets softens
Brief: STRATA Skin Sciences Q3 Revenue USD 6.9 Million
Brief: STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions